COMPANY PROFILE

Portrai

Explore full profile

Portrai the Invisibles, Redefine the medicine

Seoul, South KoreaFounded 2021Biotech & Life Sciences

Valuation $50–100M Last recorded · 2025

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Portrai

Portrai.io operates in the healthcare sector, focusing on the spatial identification of molecular markers for nanomedicine distribution within tumor tissues. The company targets researchers and healthcare professionals interested in cancer treatment advancements. By leveraging data from The Cancer Genome Atlas and single-cell RNA sequencing, Portrai.io provides insights into glucose metabolic interactions between cancer and immune cells in the tumor microenvironment. This approach aims to discover viable metabolic targets to enhance tumor immune status. The business model likely involves collaborations with research institutions and healthcare providers, generating revenue through data analysis services and potential partnerships in drug development.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2021
Headquarters: Seoul, South Korea
Employees: 20
Open positions: None listed
Dealroom signal: 80.7/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Biotech and Pharma, DT and LS, science-based
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

1 recorded event

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES B✓Equity / VC	Dec 2025	$12M	$49M	Kakao Ventures · CKD Venture Capital Corporation · Pearl Abyss Capital · BNH Investment	↗

Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

Portrai website traffic

Latest recorded traffic for Portrai is 810 monthly website visits, down 83.8% over the last three months. Portrai's team grew 17.6% over the past year.

Latest monthly visits810 3-month web change-83.8% 1-year team growth+17.6%

Monthly website visitsSep 2024–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
SBSpear BioOffers opportunities for better detections with less invasive biospecimen collection	Woburn, United States	Operational	53	$52M	$180M
HAHaiiDeveloping innovative digital therapeutics in the prevention and management of mental health and disease such as dementia, depression, and anxiety disorders	Seoul, South Korea	Operational
SYSyantraPrecision healthcare company that focuses on the commercialization of breast cancer detection blood tests	Calgary, Canada	Operational
COCorneagenInnovative corneal therapeutics and tissue services advancing ocular surgery and patient care	Seattle, United States	Operational
HEHemoraiEnables clinicians to extend acute care to the patient’s home via reliable continuous monitoring of Hemodynamics	Austin, United States	Operational
C2C2CareDesigns therapeutic solutions based on virtual reality in order to immerse patient in an environment that creates a certain stress	Sanary-sur-Mer, France	Operational
OLOverture LifeA biotechnology company that is aiming to revolutionize embryology	Alcobendas, Spain	Operational
AIActive IronHealthcare development company focused on optimizing established therapies through innovative science	Cork, Ireland	Operational